Results 251 to 260 of about 47,941 (305)

Increasing access to self-managed abortion through pharmacies: programmatic results and lessons from a pilot program in Oromia, Ethiopia. [PDF]

Front Reprod Health
Chekol BM, Belai Mehari A, Rezene B, Muluye S, Ayana Y, Sisay E, Dijkerman S, Assefa G.   +7 more
europepmc   +1 more source

Posible efecto disruptivo del Misoprostol

, 2001
Hernando Alfonso Castillo, Alejandra Giraldo   +1 more
openalex   +1 more source

Misoprostol for Tinnitus [PDF]

Annals of Pharmacotherapy, 1995
Practitioners should realize that further study of misoprostol in larger patient populations must be undertaken to determine its efficacy and safety in the treatment of tinnitus. Previous approaches to treating tinnitus have included carbamazepine, phenytoin, lidocaine, tocainide, flecainide acetate, alprazolam, and nortriptyline.
Cara L Crinnion, Gary M. McCart
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Misoprostol for labour induction

Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
Oral and vaginal misoprostol are effective induction methods, but there is a delicate balance between a quicker labour and avoiding side effects. In randomised comparisons with balloon catheters, oral misoprostol resulted in more vaginal births in the first 24 h as well as fewer caesarean sections without an increase in hyperstimulation events. Vaginal
Nimisha Kumar, Andrew Weeks, David M. Haas   +2 more
openaire   +3 more sources

Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials

Journal of Maternal-Fetal & Neonatal Medicine, 2020
Objective: To compare the effect of misoprostol combined with a cervical single or double-balloon catheter versus misoprostol alone for labor induction of singleton pregnancies with an unfavorable cervix.
Lía Ornat, Vanesa Alonso-Ventura, J. Bueno-Notivol, P. Chedraui, F. Pérez-López   +4 more
semanticscholar   +1 more source

Efficacy comparison of titrated oral solution of misoprostol and intravenous oxytocin on labour induction in women with full-term pregnancy

Journal of Obstetrics and Gynaecology Research, 2020
A double-blind randomised trial was conducted on women with gestational age of 40–42 weeks of pregnancy and Bishop score of more than 5. The first group received oxytocin infusion and the second group received a titrated oral solution of misoprostol ...
M. Kashanian, Noushin Eshraghi, M. Rahimi, N. Sheikhansari, F. Javanmanesh   +4 more
semanticscholar   +1 more source

Misoprostol administration prior to intrauterine contraceptive device insertion: a systematic review and meta-analysis of randomised controlled trials

European journal of contraception & reproductive health care, 2020
Objectives: Misoprostol has been used before intrauterine contraceptive device (IUCD) insertion to prime the cervical os. As the literature about this topic is controversial, we aimed to evaluate IUCD insertion failure, women’s pain perception, use of ...
A. Tassi, N. Parisi, A. Londero
semanticscholar   +1 more source

Misoprostol and Pregnancy

New England Journal of Medicine, 2001
Misoprostol is a prostaglandin E1 analogue that has been approved by the Food and Drug Administration (FDA) to be taken orally for the prevention and treatment of gastric ulcers associated with the use of nonsteroidal antiinflammatory drugs. It has also become an important drug in obstetrical and gynecologic practice because of its uterotonic and ...
Philip D. Darney, Alisa B. Goldberg, Mara B. Greenberg   +2 more
openaire   +3 more sources